Clinical Trials Browser

OTHER × Gallbladder Neoplasms × Trastuzumab × Clear all

NCT06178445 2025-08-19

TRAP-BTC

Phase 2 Recruiting

Gastrointestinal

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

NCT02836847 2018-05-07

Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Phase 2 Unknown

Gastrointestinal

Gallbladder Neoplasms